Caroline Mollévi
Inserm(FR)Inserm(FR)Université de Montpellier(FR)Centre Hospitalier Universitaire de Montpellier(FR)Hôpital Lapeyronie(FR)Institute for Neurosciences of Montpellier(FR)Institut de Recherche en Cancérologie de Montpellier(FR)Institut Universitaire de Recherche Clinique(FR)Centre Occitanie-Montpellier(FR)Onco Lille(FR)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Health Systems, Economic Evaluations, Quality of Life, Cancer Genomics and Diagnostics, Cancer survivorship and care, Monoclonal and Polyclonal Antibodies Research
Most-Cited Works
- → Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA(2014)680 cited
- → Impact of FOLFIRINOX Compared With Gemcitabine on Quality of Life in Patients With Metastatic Pancreatic Cancer: Results From the PRODIGE 4/ACCORD 11 Randomized Trial(2012)492 cited
- → Conventional-Dose Versus High-Dose Chemotherapy As First Salvage Treatment in Male Patients With Metastatic Germ Cell Tumors: Evidence From a Large International Database(2011)265 cited
- → Quantifying circulating cell-free DNA in humans(2019)224 cited
- → Overexpression of phosphoserine aminotransferase PSAT1 stimulates cell growth and increases chemoresistance of colon cancer cells(2008)220 cited
- → Gene Expression Signature in Advanced Colorectal Cancer Patients Select Drugs and Response for the Use of Leucovorin, Fluorouracil, and Irinotecan(2007)208 cited